Literature DB >> 19749793

Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions.

D Walerych1, M B Olszewski, M Gutkowska, A Helwak, M Zylicz, A Zylicz.   

Abstract

p53 as an unstable protein in vitro likely requires stabilizing factors to act as a tumor suppressor in vivo. Here, we show that in human cells transfected with wild-type (WT) p53, Hsp90 and Hsp70 molecular chaperones maintain the p53 native conformation under heat-shock conditions (42 degrees C) as well as assist p53 refolding at 37 degrees C, during the recovery from heat shock. We also show that the interaction of WT p53 with WAF1 promoter in cells is sensitive to Hsp70 and Hsp90 inhibition already at 37 degrees C and further decreased on heat shock. The influence of chaperones on p53 binding to the WAF1 promoter sequence has been confirmed in vitro, using highly purified proteins. Hsp90 stabilizes the binding of p53 to the promoter sequence at 37 degrees C, whereas under heat-shock conditions the requirement for the Hsp70-Hsp40 system and its cooperation with Hsp90 increases. Hop co-chaperone additionally stimulates these reactions. Interestingly, the combined Hsp90 and Hsp70-Hsp40 allow for a limited in vitro restoration of the DNA-binding activity by the p53 oncogenic variant R249S and affect its conformation in cells. Our results indicate for the first time that, especially under stress conditions, not only Hsp90 but also Hsp70 is required for the chaperoning of WT and R249S p53.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19749793     DOI: 10.1038/onc.2009.281

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

1.  Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression.

Authors:  Rajan Gogna; Esha Madan; Periannan Kuppusamy; Uttam Pati
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  ATP binding to Hsp90 is sufficient for effective chaperoning of p53 protein.

Authors:  Dawid Walerych; Malgorzata Gutkowska; Marcin P Klejman; Bartosz Wawrzynow; Zuzanna Tracz; Milena Wiech; Maciej Zylicz; Alicja Zylicz
Journal:  J Biol Chem       Date:  2010-08-05       Impact factor: 5.157

Review 3.  The Paradox of p53: What, How, and Why?

Authors:  Yael Aylon; Moshe Oren
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

Review 4.  Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction.

Authors:  Agnieszka Toma-Jonik; Natalia Vydra; Patryk Janus; Wiesława Widłak
Journal:  Cell Oncol (Dordr)       Date:  2019-06-10       Impact factor: 6.730

5.  Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine.

Authors:  Angela Chiaviello; Ida Paciello; Bianca Maria Veneziani; Giuseppe Palumbo; Salvatore M Aloj
Journal:  Med Oncol       Date:  2011-12-20       Impact factor: 3.064

6.  A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase.

Authors:  Pui-Kei Wu; Seung-Keun Hong; Sudhakar Veeranki; Mansi Karkhanis; Dmytro Starenki; Jose A Plaza; Jong-In Park
Journal:  Mol Cell Biol       Date:  2013-08-19       Impact factor: 4.272

7.  Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.

Authors:  Leixiang Yang; Tanjing Song; Qian Cheng; Lihong Chen; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2019-02-04       Impact factor: 4.272

8.  The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin.

Authors:  Veronika Kvardova; Roman Hrstka; Dawid Walerych; Petr Muller; Eva Matoulkova; Veronika Hruskova; Dagmar Stelclova; Petr Sova; Borivoj Vojtesek
Journal:  Mol Cancer       Date:  2010-06-15       Impact factor: 27.401

9.  Promoter complexity and tissue-specific expression of stress response components in Mytilus galloprovincialis, a sessile marine invertebrate species.

Authors:  Chrysa Pantzartzi; Elena Drosopoulou; Minas Yiangou; Ignat Drozdov; Sophia Tsoka; Christos A Ouzounis; Zacharias G Scouras
Journal:  PLoS Comput Biol       Date:  2010-07-08       Impact factor: 4.475

10.  The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53.

Authors:  Esha Madan; Taylor M Parker; Matthias R Bauer; Alisha Dhiman; Christopher J Pelham; Masaki Nagane; M Lakshmi Kuppusamy; Matti Holmes; Thomas R Holmes; Kranti Shaik; Kevin Shee; Salome Kiparoidze; Sean D Smith; Yu-Soon A Park; Jennifer J Gomm; Louise J Jones; Ana R Tomás; Ana C Cunha; Karuppaiyah Selvendiran; Laura A Hansen; Alan R Fersht; Kálmán Hideg; Rajan Gogna; Periannan Kuppusamy
Journal:  J Biol Chem       Date:  2018-01-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.